APOA1 Gene Hypoalphalipoproteinemia Genetic Test
At DNA Labs UAE, we offer the APOA1 Gene Hypoalphalipoproteinemia Genetic Test to help diagnose and understand this condition. Read on to learn more about the test, its components, cost, symptoms, and diagnosis process.
Test Name: APOA1 Gene Hypoalphalipoproteinemia Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Before undergoing the APOA1 Gene Hypoalphalipoproteinemia Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by Hypoalphalipoproteinemia.
Test Details
The APOA1 gene is responsible for producing the apolipoprotein A1 (apoA1) protein, which is a major component of high-density lipoprotein (HDL) particles. HDL, also known as “good cholesterol,” helps remove excess cholesterol from the bloodstream and transports it to the liver for processing.
Hypoalphalipoproteinemia is a condition characterized by low levels of HDL cholesterol in the blood. This can increase the risk of developing cardiovascular diseases, such as atherosclerosis and heart disease.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify genetic variations associated with a particular condition or disease. In the case of hypoalphalipoproteinemia, NGS genetic testing can identify variations or mutations in the APOA1 gene that may be responsible for the low levels of HDL cholesterol.
By identifying these genetic variations, healthcare providers can better understand the underlying cause of hypoalphalipoproteinemia in an individual and develop personalized treatment plans. This may involve lifestyle modifications, such as dietary changes and increased physical activity, as well as medication options to manage cholesterol levels and reduce the risk of cardiovascular diseases.
| Test Name | APOA1 Gene Hypoalphalipoproteinemia Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for APOA1 Gene Hypoalphalipoproteinemia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoalphalipoproteinemia |
| Test Details |
The APOA1 gene is responsible for producing the apolipoprotein A1 (apoA1) protein, which is a major component of high-density lipoprotein (HDL) particles. HDL is often referred to as “good cholesterol” because it helps remove excess cholesterol from the bloodstream and transports it to the liver for processing. Hypoalphalipoproteinemia is a condition characterized by low levels of HDL cholesterol in the blood. This can increase the risk of developing cardiovascular diseases, such as atherosclerosis and heart disease. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously and identify genetic variations that may be associated with a particular condition or disease. In the case of hypoalphalipoproteinemia, NGS genetic testing can be used to identify variations or mutations in the APOA1 gene that may be responsible for the low levels of HDL cholesterol. By identifying these genetic variations, healthcare providers can better understand the underlying cause of hypoalphalipoproteinemia in an individual and develop personalized treatment plans. This may involve lifestyle modifications, such as dietary changes and increased physical activity, as well as medication options to manage cholesterol levels and reduce the risk of cardiovascular diseases. |
